Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The DUO-O ovarian cancer trial record is now displayed, including its study design, treatments, eligibility criteria, participating locations, and outcome measures. The record also includes posted results and supporting study documents.
    Difference
    100%
    Check dated 2026-11-11T17:14:14.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.2 to v3.8.0, while the study record still displays a 403 error.
    Difference
    0.3%
    Check dated 2026-10-28T15:32:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates to terminology during a transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T20:47:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer's revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T20:43:37.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:50:53.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected content with an error message. The page retains standard site chrome (navigation/footer), indicating restricted access to the record.
    Difference
    0.5%
    Check dated 2026-09-30T22:13:25.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.